Killing Insect Pests Inside Wood By Vacuum Dehydration
    11.
    发明申请
    Killing Insect Pests Inside Wood By Vacuum Dehydration 失效
    通过真空脱水杀死木材内的昆虫害虫

    公开(公告)号:US20080127548A1

    公开(公告)日:2008-06-05

    申请号:US11574551

    申请日:2005-07-11

    IPC分类号: A01M1/06

    摘要: Insect pests can be transported around the world in wooden shipping containers. To prevent the spread of woodborne insect pests, it is necessary to kill insects within the wood. The wood is placed in a vacuum container having a flexible wall. The flexible wall presses against the wood and enables the wood to be heated by conduction. The wood and flexible wall can to be heated by contact with ambient or heated air, for example. Desiccant or dry air can be used to increase the rate of dehydration. Insects in the wood are typically killed after losing 25-50% of their body weight by dehydration. This technique will kill beetle larvae, nematodes and other invasive and destructive insects that live inside solid wood, and is particularly applicable for rendering wood acceptable for use in pallets and other containers shipped internationally.

    摘要翻译: 昆虫害虫可以运送到世界各地的木制运输集装箱。 为了防止木本虫害的传播,有必要杀死木材内的昆虫。 将木材放置在具有柔性壁的真空容器中。 柔性壁压在木材上,使木材能够被传导加热。 例如,木材和柔性壁可以通过与环境或加热的空气接触来加热。 干燥剂或干燥空气可用于提高脱水率。 木材中的昆虫通常脱水失去体重的25-50%之后就会死亡。 这种技术将杀死住实木内的甲虫幼虫,线虫和其他侵入性和破坏性的昆虫,特别适用于木材可接受用于国际运输的托盘和其他容器。

    Video control gloves
    12.
    发明授权
    Video control gloves 失效
    视频控制手套

    公开(公告)号:US4613139A

    公开(公告)日:1986-09-23

    申请号:US679989

    申请日:1984-12-10

    摘要: Apparatus for providing switch closure control inputs to a joystick control port of a video console comprising a pair of gloves having separate finger and thumb portions with electrical contacts mounted on the palm surfaces thereof adjacent to the finger and thumb tips. The electrical contacts are connected to selected terminals of a connector adapted for removable insertion into the console control port. Physical contact between the finger and thumb tips obtains electrical connection between associated contacts so as to provide switch closure control inputs to associated terminals of the control port.

    摘要翻译: 用于向视频控制台的操纵杆控制端口提供开关闭合控制输入的装置,包括一对手套,该手套具有独立的手指和拇指部分,其中电触点安装在手指和拇指尖端的手掌表面上。 电触头连接到适于可拆卸插入控制台控制端口的连接器的选定端子。 手指和拇指尖之间的物理接触获得相关联的触点之间的电连接,以便向控制端口的相关端子提供开关闭合控制输入。

    Plasma Carboxypeptidase B as a Predictor for Disease Severity and Response
    15.
    发明申请
    Plasma Carboxypeptidase B as a Predictor for Disease Severity and Response 审中-公开
    血浆羧肽酶B作为疾病严重程度和反应的预测因子

    公开(公告)号:US20130052186A1

    公开(公告)日:2013-02-28

    申请号:US13492099

    申请日:2012-06-08

    摘要: Compositions and methods are provided for prognostic classification of individuals into groups that are informative of the individual's likelihood of developing severe disease associated with undesirable complement activation. Individuals having one or both alleles for a more stable or active carboxypeptidase B variant have a reduced propensity for developing severe disease. The presence of the protective variant may be identified through any suitable method.

    摘要翻译: 提供组合物和方法用于将个体预测分类成组,其中提供个体与发生与不期望的补体活化相关的严重疾病的可能性的可能性。 具有一个或两个更稳定或活性的羧肽酶B变体的等位基因的个体具有降低的发展严重疾病的倾向。 可以通过任何合适的方法鉴定保护性变体的存在。

    Alpha B-crystallin as a therapy for rheumatoid arthritis
    17.
    发明授权
    Alpha B-crystallin as a therapy for rheumatoid arthritis 有权
    αB结晶蛋白作为类风湿关节炎的治疗方法

    公开(公告)号:US07875589B2

    公开(公告)日:2011-01-25

    申请号:US12001553

    申请日:2007-12-11

    IPC分类号: A61K38/16

    CPC分类号: A61K31/711 A61K38/1709

    摘要: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

    摘要翻译: 本发明提供了通过向受试者施用有效量的提供αB-晶状蛋白活性的药剂来治疗炎性疾病的方法,其中剂量有效地抑制或预防疾病的起始,进展或复发,包括已建立的 疾病。 在一些实施方案中,本发明的方法包括向具有预先存在的炎症疾病状况的受试者施用有效量的α-B-晶状蛋白,以抑制或预防疾病的复发。

    Container and closure assembly
    18.
    发明授权
    Container and closure assembly 失效
    集装箱和封闭装置

    公开(公告)号:US4066181A

    公开(公告)日:1978-01-03

    申请号:US667290

    申请日:1976-03-16

    IPC分类号: B65D41/48 B65D51/14 B65D41/32

    摘要: A container and closure assembly wherein the container is adapted to be initially closed by a sealing means such as a vacuum disc. The closure has two positions of attachment to a bead encircling the container. In the first position of attachment, which accommodates the aforementioned sealing means, the container bead is engaged in an annular notch located in the inside wall of a closure skirt. The notch weakens the skirt so as to allow a distal end of the skirt to be torn from a remaining portion of the closure to free the remaining portion of the closure from attachment to the container bead. This exposes the sealing means so as to allow a removal thereof and access to the contents of the container. The remaining portion of the closure is then reattachable to the container bead at a second position of attachment rendered accessible by removal of the sealing means for reclosure of the container. In a first embodiment, the closure has retention ribs permitting preassembly of the sealing means to the closure. In a modification, the retention means comprises an inwardly directed skirt bead sized to retain the sealing means.

    Alpha B-crystallin as a therapy for multiple sclerosis
    19.
    发明授权
    Alpha B-crystallin as a therapy for multiple sclerosis 有权
    αB晶状蛋白作为多发性硬化症的治疗

    公开(公告)号:US08835391B2

    公开(公告)日:2014-09-16

    申请号:US12931001

    申请日:2011-01-21

    CPC分类号: A61K31/711 A61K38/1709

    摘要: The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

    摘要翻译: 本发明提供了通过向受试者施用有效量的提供αB-晶状蛋白活性的药剂来治疗炎性疾病的方法,其中剂量有效地抑制或预防疾病的起始,进展或复发,包括已建立的 疾病。 在一些实施方案中,本发明的方法包括向具有预先存在的炎症疾病状况的受试者施用有效量的α-B-晶状蛋白,以抑制或预防疾病的复发。